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Arabinogalactan (AG) is an essential structural macromolecule present in the cell wall of Mycobacterium
tuberculosis, serving to connect peptidoglycan with the outer mycolic acid layer. The D-arabinan segment
is a highly branched component of AG and is assembled in a step-wise fashion by a variety of arabinofu-
ranosyltransferases (AraT). We have previously used Corynebacterium glutamicum as a model organism to
study these complex processes which are otherwise essential in mycobacteria. In order to further our
understanding of the molecular basis of AG assembly, we investigated the role of a fourth AraT, now ter-
med AftD by generating single (DaftD) and double deletion (DaftB DaftD) mutants of C. glutamicum. We
demonstrate that AftD functions as an a(1? 5) AraT and reveal the point at which it exerts its activity in
the AG biosynthetic pathway.
 2017 The Authors. Published by Elsevier B.V. This is anopenaccess article under the CCBY license (http://
creativecommons.org/licenses/by/4.0/).Introduction
TheMycobacterium tuberculosis cell wall is dominated by a com-
plex heteropolysaccharide termed arabinogalactan (AG) that
serves to connect the peptidoglycan (PG) sacculus to the outer
‘myco-membrane’ (Bhowruth et al., 2008). The presence of AG in
the cell wall core is a common feature of the Corynebacteriales,
members of which include Corynebacteria, Nocardia, Rhodobacter
and Mycobacteria (Daffe et al., 1993, Dover et al., 2004, Wesener
et al., 2017). Although these organisms exist in a variety of differ-
ent environments, the core structural features common to AG are
based upon a common carbohydrate structure.
Interspersed throughout the glycan strands of mycobacterial
PG, some of the muramic acid residues serve as sites of AG attach-
ment in which the 6-hydroxyl is covalently bonded via a phospho-
diester to an N-acetylglucosamine residue, which is a(1? 3)
linked to L-rhamnose, forming a motif commonly known as the lin-
ker unit (LU) (McNeil et al., 1990). The LU is attached to a linear
galactan polysaccharide composed of approximately 30 galactofu-
ranose (Galf) residues that extend in an alternating b(1? 5) and b
(1? 6) fashion (Fig. 1A) (Daffé et al., 1990, Daffe et al., 1993, Besra
et al., 1995). This galactan ‘‘backbone” is decorated with threearabinan chains, which are specifically located at the 8th, 10th
and 12th positions (Alderwick et al., 2005). Each arabinan domain
is composed of approximately 30 arabinofuranose (Araf) residues
that are arranged into a structure that becomes increasingly
branched and the overall structure depends entirely upon the
arrangement of three major ‘glycosidic motifs’ (Fig. 1A) (Besra
et al., 1995). The arabinan polysaccharide is branched by virtue
of an a(1? 3) linked Araf unit positioned at approximately 13
residues along the linear arabinan chain (Besra et al., 1995). The
resulting branch point is then extended by an additional stretch
of five a(1? 5) linked Araf residues. Each of these bifurcated
strands are again branched in an a(1? 3) dependent manner
before terminating in a characteristic hexasaccharide, [Araf-b(1
? 2)-Araf-a(1? ]2–3,5)-Araf-a(1? 5)-Araf, often referred to as
the ‘hexaarabinofuranosyl motif’ (Besra et al., 1995, Daffé et al.,
1990, Daffe et al., 1993, McNeil et al., 1994). A single fully matured
arabinan domain provides a total of 8 possible sites for the esteri-
fication of cell wall bound mycolates, ultimately forming the myco
lyl-ArabinoGalactan-Peptidoglycan (mAGP) complex (McNeil et al.,
1991).
Recently, our understanding of the AG biosynthetic pathway
has significantly improved. This is largely a result of using surro-
gate laboratory ‘‘model systems” to investigate the deletion of cor-
responding orthologous genes, which are otherwise essential in
mycobacteria. In this regard, Corynebacterium glutamicum is an
excellent model system for studying mycobacterial cell wall
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2015; Alderwick et al., 2006a; Birch et al., 2009). We have charac-
terised several novel arabinofuranosyltransferases (AraTs) which
are crucial for the assembly of AG. AftA is responsible for ‘‘priming”
the galactan core thrice with single Araf residues which is then
elongated in an a(1? 5) processive manner (Alderwick et al.,
2006b). The AraT responsible for this activity in C. glutamicum is
encoded by the single emb gene (NCgl0184), which if deleted via
homologous recombination, results in a viable strain that exhibits
a severely reduced growth phenotype and a dramatically altered
cell wall composition (Alderwick et al., 2005). The M. tuberculosisgenome encodes for three Cg-emb orthologs annotated as embA,
embB and embC (with embC displaying closest sequence homology
of the three) that have been shown to be targeted by the front-line
anti-TB drug ethambutol (EMB) (Belanger et al., 1996, Telenti et al.,
1997). The terminal b(1? 2) capping enzyme AftB and the
a(1? 3) branching enzyme AftC were also identified as key
enzymes involved in the formation of the non-reducing terminus
of AG (Birch et al., 2008, Seidel et al., 2007a). One of the most strik-
ing features of these AraTs is that they all belong to the GT-C
superfamily of glycosyltransferases. GT-C glycosyltransferases are
polytopic integral membrane proteins, often containing an N- or
C-terminal ‘‘globular” domain which also utilize lipid-linked sugar
donors (Liu and Mushegian, 2003). AftD is the fourth member of
this GT-C family of AraTs and gene knock out experiments per-
formed in M. smegmatis suggested that aftD was essential for the
viability and growth of M. smegmatis (Skovierova et al., 2009).
The essential nature of Ms-aftD afforded no phenotypic analysis
of the mutant, therefore the authors assigned the function of
Ms-aftD using over-expression experiments, with subsequent bio-
chemical analyses in order to determine what downstream effects
this over-expression had on the physiology and chemistry of the
cell wall AG (Skovierova et al., 2009). These authors concluded that
aftD encoded for a second branching a(1? 3) AraT, similar in
function to that of AftC (Birch et al., 2008).
Herein, we report a comprehensive phenotypic characterisation
of two modified strains of C. glutamicum, one of which has been
deleted of its Mt-aftD ortholog (NCgl2757) in addition to a double
mutant which has also been deleted of the terminal b(1? 2) cap-
ping arabinofuranosyltransferase, aftB. We present evidence,
which provides an alternative explanation for the function of AftD
as an a(1? 5) arabinofuranosyltransferase responsible for elon-
gating the a(1? 3) primed bifurcation strands of the arabinan
found in AG.Material and methods
Strains and culture conditions
C. glutamicum strains were grown on complex medium (Brain
Heart Infusion, Difco), or on salt medium CGXII (Eggeling and
Reyes, 2005), with cultivation at 30 C. Growth curves wereFig. 1A. Common glycosyl linkage motifs found within mycobacteria and
corynebacteria (A), topology of AftD (B), knock out strategy (C) and effect on
growth in liquid media (D). A, The hexaarabinosyl (motif) 1 is the site of mycolic
acid esterification, the [a-D-Araf(1? 5]-a-D-Araf (motif 2) represents the main
linear segments of D-arabinan, the [a-D-Araf(1? ]3,5-a-D-Araf (motif 2) illustrates
the main bifurcation points of a single D-arabinan chain, and motifs 4 and 5 show
the linkage profiles of linear D-galactan configuration of how D-arabinan is
attached to D-galactan. B, topology of C. glutamicum AftD with the black triangle
indicating the location of the 388 aa insertion in theM. tuberculosis ortholog of AftD.
The topology prediction is based on the dense alignment surface method. The
conserved aspartyl and glutamyl residues are indicated as D and E, respectively. The
star indicates the two catalytic motifs resembling those of glycosyltransferases of
the GT-C family (Liu and Mushegian, 2003). C, strategy to construct C. glutam-
icumDaftD. Shown is the wild type genomic aftD-region and the deletion vector
pK19mobsacBDaftD carrying 18 nucleotides of the 50-end of aftD and 36 nucleotides
of its 30-end thereby enabling the in-frame deletion of almost the entire Cg-aftD
gene. Selection for homologous recombination results in C. glutamicumDaftD (Cg-
aftD). The arrows marked P1 and P2 locate the primers used for the PCR analysis to
confirm the absence of Cg-aftD. Distances are not drawn to scale. The results of the
PCR analysis are shown on the right, where the amplification product obtained from
the wild type (WT) and that of the deletion mutant of (D) was marked accordingly.
The sizes of 4032 bp for the wild type and of 1051 bp for the deletion mutant were
as expected and marked by an arrow head. St marks the standard. D, the
consequences of Cg-aftD deletion and Cg-aftB/Cg-aftD double deletion on growth
in rich medium (BHI). Growth of C. glutamicum (d), C. glutamicumDaftD (j), C.
glutamicumDaftD (▲) and C. glutamicumDaftBDaftD (D).
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fled Erlenmeyer flasks, which were incubated at 120 rpm and orbi-
tal shaking for 50 mm (Kühner, Basel, Switzerland). Escherichia coli
strains were grown on LB at 37 C. Kanamycin and ampicillin were
used at a concentration of 50 mg/ml and 100 mg/ml respectively.
Samples for cell wall analysis were prepared by harvesting cells
at an optical density of 10–15 followed by a saline wash and freeze
drying (Alderwick et al., 2005).
Construction of plasmids and strains
The expression vectors made were pVWEx-Cg-aftD (NCgl2757),
pVWEx-Mt-aftD (Rv0236c) and the deletion vector pK19mob-
sacBDaftD (NCgl2757) with the gene number of the C. glutamicum
and M. tuberculosis aftD orthologs added in parentheses. To enable
in-frame deletion of aftD crossover PCR was applied with primer
pairs AB (A, 50-CGCTTCTAGACCACGTCATGGCATACGAAACTG-30; B,
50-CCCATCCACTAAACTTAAACACACCACAAAACCCAGCAC-30) and
CD (C, 50-TGTTTAAGTTTAGTGGATGGGGCTGCGCTATTTGCTGG-30;
D, 50-GCGGGAATTCGCATGGCAAGCCGGTAAG-30) and genomic
DNA of the wild type of C. glutamicum (ATCC13032) used as tem-
plate. Both amplified products were used in a second PCR with pri-
mer pairs AD to generate a 620 bp fragment consisting of
sequences adjacent to Cg-aftD, which was ligated with XbaI-
EcoRI-cleaved pK19mobsacB.
For the construction of pVWEx-Mt-aftD M. tuberculosis H37Rv
DNA was used as template obtained from the Tuberculosis
Research Material Contract (National Institutes of Health) at Color-
ado State University. Since the direct amplification of the 4203 bp
aftD gene product proofed difficult, crossover PCR was applied with
primer pairs EF (E, 50-TACCGAGCTCGAATTCAAGGAGATATA
GATGTGGCGCCGTTGTCTCGCAAATG-30; F, 50-CGAGGAGCTCGA
CACGGTGATC-30) and GH (G, 50-GACGGCCAGTGAATTCCTATTG
CATGCGGTCTTGACCACGAGACTC-30; H, 50-GATCACCGTGTC
GAGCTCCTCG-30), using the pair EG in the second PCR. The result-
ing product was cloned into pEKEx2 using poxvirus DNA poly-
merase of the In-Fusion kit (Clontech, Takara Bio Inc, Japan). To
construct pVWEx-Cg-aftD, the primer pairs 50-GATTAACTGCA
GAGGGAGATATAGGTGCTGGGTTTTGTGG-30 and 50-GCCGTCTCTA
GATTAGCGCTTTGGAGGCC-30 were used to amplify NCgl2757 plus
4 additional codons at the 5‘-end. The product was purified and
ligated with PstI-XbaI-treated pVWEx1.
All plasmid inserts were confirmed by sequencing. The chromo-
somal deletion of Cg-aftD was performed as described previously
using two rounds of positive selection (Schafer et al., 1994), and
its successful deletion was verified by use of two different primer
pairs hybridizing in the genome. Plasmids were introduced into
C. glutamicum by electroporation with selection to kanamycin
resistance (25 mg/ml) on BHI. In order to construct the aftB/aftD
double mutant C. glutamicumDaftBDaftD, the deletion vector pK19-
mobsacBDaftD was also used and introduced into the previously
reported strain C. glutamicumDaftB (Seidel et al., 2007a).
Isolation of the mAGP complex, glycosyl composition and linkage
analysis of alditol acetates by GC and GC/MS
The thawed cells were resuspended in phosphate buffered sal-
ine containing 2% Triton X-100 (pH 7.2), disrupted by sonication
and centrifuged at 27,000g (Alderwick et al., 2005, Besra et al.,
1995). The pelleted material was extracted three times with 2%
SDS in phosphate buffered saline at 95 C for 1 h, washed with
water, 80% (v/v) acetone in water, and acetone, and finally lyophi-
lised to yield a highly purified cell wall preparation (Alderwick
et al., 2005, Besra et al., 1995). Cell wall or per-O-methylated cell
wall preparations (Alderwick et al., 2005) were hydrolyzed in 2
M TFA, reduced with NaB2H4 and the resultant alditols per-O-acetylated and examined by GC and GC/MS as described previously
(Alderwick et al., 2005, Besra et al., 1995).
Arabinofuranosyltransferase activity with membrane preparations of
C. glutamicum, C. glutamicumDaftB, C. glutamicumDaftD and C.
glutamicumDaftBDaftD
Membranes were prepared as described previously (Birch et al.,
2008, Lee et al., 1997, Seidel et al., 2007a) and resuspended in 50
mM MOPS (pH 7.9), containing 5 mM b-mercaptoethanol and 10
mM MgCl2 (buffer A) to a final protein concentration of 15–10
mg/ml. The neoglycolipid acceptors used in this study were a-D-
Araf(1? 3)-a-D-Araf-O-(CH2)7CH3 (acceptor A) and a branched
trisaccharide [a-D-Araf(1? ]3,5-a-D-Araf-O-(CH2)7CH3 (acceptor
B) (Lee et al., 1997). The acceptors (A and B) (Lee et al., 1997)
(stored in ethanol) and decaprenol monophosphate (stored in
CHCl3/CH3OH, 2:1. v/v) were aliquoted into 1.5 ml eppendorf tubes
to a final concentration of 2 mM and 5 lg/ml, respectively, and
dried under compressed nitrogen. The arabinofuranosyltransferase
assay was carried out as described previously (Lee et al., 1997)
with modifications. IgePalTM (Sigma–Aldrich) was added (0.1%, v/
v) with the appropriate amount of buffer A (final volume 80 ll).
Tubes were sonicated for 15 min to resuspend lipid linked sub-
strates and then mixed with the remaining assay components,
which included membrane protein from either C. glutamicum, C.
glutamicumDaftB, C. glutamicumDaftD and C. glutam-
icumDaftBDaftD (1 mg), 1 mM ATP, 1 mM NADP and in some cases
EMB (0.1 mg/ml). Assays were initiated with the addition of
100,000 cpm p[14C]Rpp and incubated for 2 h at 37 C and
quenched by the addition of 533 ll CHCl3/CH3OH (1:1, v/v). After
mixing and centrifugation at 27,000g for 15 min at 4 C, the
supernatant was removed and dried under nitrogen. The residue
was then resuspended in 700 ll of CH3CH2OH/H2O (1:1, v/v) and
loaded onto a 1 ml SepPak strong anion exchange cartridge
(Supelco), pre-equilibrated with CH3CH2OH/H2O (1:1, v/v). The col-
umn was washed with 2 ml CH3CH2OH and the eluate collected,
dried and partitioned between the two phases arising from a mix-
ture of n-butanol (3 ml) and water (3 ml). The resulting organic
phase was recovered following centrifugation at 3500g and the
aqueous phase again extracted twice with 3 ml of water-
saturated n-butanol. The pooled extracts were back-washed twice
with n-butanol-saturated water (3 ml). The n-butanol fraction was
dried and resuspended in 200 ll butanol. The extracted radiola-
belled material was quantified by liquid scintillation counting
using 10% of the labelled material and 5 ml of EcoScintA (National
Diagnostics, Atlanta). The incorporation of [14C]Araf was deter-
mined by subtracting counts present in control assays (incubations
in the absence of acceptor). The remaining labelled material was
subjected to thin-layer chromatography (TLC) using isopropanol:
acetic acid:water (8:1:1, v/v/v) on aluminium-backed Silica Gel
60 F254 plates (Merk, Darmstadt, Germany). Autoradiograms were
obtained by exposing TLCs to X-ray film (Kodak X-Omat) for 3
days.
Characterisation of AftD responsible for a(1? 5)-arabinofuranosyl
transferase activity with membranes prepared from C. glutamicum,
C. glutamicumDaftB, C. glutamicumDaftD and C.
glutamicumDaftBDaftD
Large-scale reaction mixtures containing cold DPA (200 lg,
0.75 mM) (Lee et al., 1997) and 50 mM of either acceptor A or
acceptor B, were mixed and given an initial 1 h incubation at 37
C with membranes prepared from either C. glutamicum,
C. glutamicumDaftB, C. glutamicumDaftD, C. glutamicumDaftBDaftD
and C. glutamicumDaftBDaftD pVWEx-Mt-aftD. The assays were
replenished with fresh membranes (1 mg) and re-incubated for
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extracted from reaction mixtures by n-butanol/water phase sepa-
ration as described earlier to extract products. Products were
applied to preparative TLC plates, developed in isopropanol:acetic
acid:water (8:1:1, v/v/v) and sprayed with 0.01% 1,6-
diphenylhexatriene in petroleum-ether:acetone (9:1, v/v), and
the products localized under long-wave (366 nm) UV light (Lee
et al., 1997). The plate was then re-developed in toluene to remove
the reagent and the bands recovered from the plates by extraction
with n-butanol. The butanol phases were washed with water satu-
rated with n-butanol and the dried products subjected to GC/MS as
described (Lee et al., 1997, Alderwick et al., 2006b) and analysed by
electrospray mass spectrometry (ES-MS) in the positive mode on a
Micromass LCT mass spectrometer as described previously (Lee
et al., 1997).
Results
Genome comparison of the aftD locus
An in silico analysis of the Rv0236c open reading frame from M.
tuberculosis as well as its ortholog (NCgl2757) from C. glutamicum
revealed a conserved syntenic region which is present in all species
belonging to the order Corynebacteriales (Fig. S1). Our in silico anal-
yses support the initial report of Skovierova et al. (2009) who origi-
nally annotated this gene by the acronym aftD (arabinofuranosyltrans
ferase D).
The C. glutamicum AftD (Cg-AftD) variant is a polytopic mem-
brane protein of 1015 aa. TMHMM predictive modelling indicates
that Cg-AftD possesses 14 transmembrane a-helices (TMHs)
(Sonnhammer et al., 1998) with a long extended loop of 510 aa
separating the first 10 TMHs of the protein from the final 4
C-terminal TMHs (Fig. 1B). The various residues contributing to
AftD catalytic activity are expected to reside within the
N-terminal region of the protein. Indeed, a conserved glycosyl-
transferase motif, DX3DX18D, characteristic for the GT-C family is
located immediately after TMH6 and is marked by a star (Fig. 1B)
(Liu and Mushegian, 2003). Interestingly, a second structurally
related motif, DX2EX12E, is present between THM10 and TMH11.
The C-terminal half of Cg-AftD is predicted to contain a
carbohydrate-binding module (CBM) at position 619–740. Several
examples of proteins containing such CBM domains, include the
periplasmic polygalacturonic acid binding protein from Yersinia
enterocolitica (Abbott et al., 2007), a lectin-related virulence factor
of Streptococcus pneumoniae (Boraston et al., 2006) and perhaps
more significantly, the C-terminal CBM domain of theM. tuberculo-
sis EmbCCT (Alderwick et al., 2011). The Mt-AftD protein is larger
than its corynebacterial counterpart (Cg-AftD) by up to 388 aa,
which is due to an insert in the loop region (707–830 in
Mt-AftD), as marked by a black triangle (Fig. 1B). An additional
insertion in Mt-AftD (position 1022-1253) represents another
CBM similar to that of the cyclodextrin glycosyltransferase present
in Bacillus circulans (Uitdehaag et al., 1999).
Construction and growth of mutants
The non-replicative vector pK19mobsacBDaftD was used to
transform C. glutamicum to kanamycin resistance, indicating inte-
gration in its chromosome. For selection of the second recombina-
tion event clones were cultivated on sucrose, and 12 SucR-KanS
clones analysed via PCR with the primer pair P1/P2 (Fig. 1C). This
resulted in 4 clones with a 4032 bp fragment as expected for the
wild type, whereas 8 clones afforded a 1051 bp fragment and dele-
tion of aftD. One deletion mutant was termed C. glutamicumDaftD.In addition, aftD was also deleted in strain C. glutamicum DaftB
(Seidel et al., 2007a) to achieve the double mutant C. glutam-
icumDaftBDaftD. Growth of C. glutamicumDaftD on the salt med-
ium CGXII was not influenced (data not shown), whereas on the
complex medium BHI (Difco) a significantly reduced growth rate
of 0.48 h1 was observed as compared to wild type exhibiting a
growth rate of 0.62 h1 (Fig. 1D). Upon reintroduction of aftD in
the deletion mutant, as was the case in C. glutamicumDaftD
pVWEx-Cg-aftD, growth was fully restored (Fig. S2A). Interestingly,
with pVWEx-Mt-aftD a negative effect on growth was observed
which we interpret as expression of the mycobacterial ortholog,
potentially causing some incomplete integration of the protein into
the membrane of the heterologous host (Fig. S2A). The double
mutant C. glutamicumDaftBDaftD exhibited an even further
reduced growth rate of 0.40 h1, whereas the growth rate of
the single mutant C. glutamicumDaftB was unaffected (Fig. 1D).
The complemented double mutants, expressing either Cg-aftD or
Mt-aftD, revealed the former with a growth phenotype similar to
C. glutamicumDaftB and the latter having little positive restorative
effect (Fig. S2B).Cell wall lipid analysis of C. glutamicum and mutant strains
After generating a variety of C. glutamicum mutant and
complemented strains, we conducted a phenotypic analysis of the
lipid profiles exhibited by C. glutamicum, C. glutamicumDaftB,
C. glutamicumDaftD, C. glutamicumDaftD pVWEx-Cg-aftD, C. glutam-
icumDaftD pVWEx-Mt-aftD, C. glutamicumDaftBDaftD, C. glutamicum
DaftBDaftD pVWEx-Cg-aftD and C. glutamicumDaftBDaftD pVWEx-
Mt-aftD. Each of these eight strains was cultured to mid-log phase
in complex liquid media before pulse labelling with [14C]-acetic acid
and the ‘‘free” and ‘‘cell wall bound” corynemycolic acid profiles
analysed as described previously (Alderwick et al., 2006b, Birch
et al., 2008, Seidel et al., 2007a,b). Thin layer chromatography
(TLC) analysis revealed some subtle, yet important, alterations in
the profile of the extractable ‘‘free lipids” (Fig. S3A). The lipid profile
obtained for C. glutamicumDaftB is consistent with previously
published results, whereby an accumulation of trehalose monocoro-
nomycolate (TMCM) occurs (Seidel et al., 2007a). Similarly, an
increase in TMCM can also be observed for C. glutamicumDaftD
and C. glutamicumDaftBDaftD (Fig. S3A). This is an interesting obser-
vation since we have previously observed an almost identical alter-
ation in the phenotype of the extractable free lipids for similar AraT
knock outs in C. glutamicum, such as emb (Alderwick et al., 2005),
aftA (Alderwick et al., 2006b), aftB (Seidel et al., 2007a) and also in
M. smegmatis deleted of aftC (Birch et al., 2008). Table 1 summarises
the alterations in the composition cell wall lipids of the mutant
strains relative to the C. glutamicum wild type strain.
Cell wall bound corynemycolates were released from the delip-
idated cells of each strain under investigation and subsequently
chemically modified to produce corynemycolic acid methyl esters
(CMAME) and subjected to TLC and densitometry analysis
(Fig. S3B). As summarised in Table 1, there was a marked reduction
in the band corresponding to corynemycolates esterified to cell
wall AG in the aftB deletion strain (reduced by 70%) which was
barely affected in the DaftD strain. In comparison to C. glutam-
icumDaftB, C. glutamicumDaftBDaftD displayed a further reduction
in CMAMEs which when complemented with a plasmid expressing
aftD from either C. glutamicum (Cg-aftD) or M. tuberculosis (Mt-
aftD), failed to restore the phenotype to the expected levels similar
to that of a DaftB strain (Fig. S3B). In order to make a proper inter-
pretation of these cell wall lipid phenotypes, we continued our
study of these mutant strains by investigating the sugar composi-
tion of the cell wall AG.
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glutamicum and C. glutamicum mutant strains
Highly purified mAGP cell wall material was isolated from the
following strains, C. glutamicum, C. glutamicumDaftB, C. glutam-
icumDaftD, C. glutamicumDaftBDaftD, C. glutamicumDaftD
pVWEx-Cg-aftD, C. glutamicumDaftD pVWEx-Mt-aftD, C. glutam-
icumDaftBDaftD pVWEx-Cg-aftD and C. glutamicumDaftBDaftD
pVWEx-Mt-aftD. The purified mAGP was then chemically deriva-
tized to alditol acetates and analysed by gas chromatography
(GC) (Fig. S4) (Alderwick et al., 2005). The mAGP carbohydrate
composition of all eight C. glutamicum strains (from Fig. S4) are
summarised in Table 1. No significant change in the Ara:Gal ratio
could be detected for C. glutamicumDaftB (Seidel et al., 2007a).
However, in the case of C. glutamicumDaftD, a 7.3% decrease in
the content of Ara in the isolated AG was observed. Due to only a
slight reduction in the Ara content in C. glutamicumDaftD, it is dif-
ficult to make any clear statement regarding the phenotype of C.
glutamicumDaftD upon complementation with a plasmid express-
ing either Cg-aftD orMt-aftD. However, our data suggests that com-
plementation with either Cg-aftD or Mt-aftD restored the mutant
phenotype to almost that of a wild type situation (Ara:Gal ratio
of 2.76:1 and 2.46:1, respectively). Interestingly, the glycosyl com-
positional analysis of the double mutant C. glutamicumDaftBDaftD,
afforded a significant relative increase in the content of cell wall
Ara (+11.3%). Furthermore, only a moderate alteration of this phe-
notype occurred upon the reintroduction of Cg-aftD orMt-aftD into
C. glutamicumDaftBDaftD which mirrors the observations regard-
ing the CMAME analysis of these complemented strains (Fig. S3B,
Table 1). In order to establish the precise function of AftD, in terms
of its role as a cell wall biosynthetic GT-C glycosyltransferase, we
investigated the glycosidic linkage profiles of AG isolated from
each of the C. glutamicum strains.
Structural characterisation of AG isolated from C. glutamicum and
mutant strains
Gas chromatography mass spectrometry (GC/MS) was used to
analyze the partially O-methylated alditol acetate derivatives of
mAGP isolated from C. glutamicum, C. glutamicumDaftB, C. glutam-
icumDaftD and C. glutamicumDaftBDaftD (Fig. 2A, Table 1). The AG
isolated from C. glutamicumDaftB was completely devoid of any
terminal b(1? 2) linked Araf residues (Seidel et al., 2007a). Glyco-
syl linkage analysis from AG isolated from C. glutamicumDaftD sug-
gested only a moderate reduction in the peak at a RT of 12.1 min,
which corresponds to a slight decrease in 5-Araf glycosidic linkages
(Fig. 2A, Table 1). The abundance of all other peaks, which repre-
sent the remaining glycosidic linkages remain unchanged (when
compared to the WT profile) (Fig. 2A, Table 1). Here, it is important
to note that the 2-Araf peak is present in C. glutamicumDaftD, as
confirmed by the mass fragmentation profile illustrated in
Fig. 2B. Reintroduction of a plasmid encoding either Cg-aftD or
Mt-aftD into C. glutamicumDaftD resulted in a glycosidic linkage
phenotype almost identical to that of the wild type (Fig. S5 and
Table 1). Interestingly, the GC/MS profile of the C. glutam-
icumDaftBDaftD mutant displays some unique properties as com-
pared to the other three profiles as illustrated in Fig. 2A. In
addition to the loss of 2-Araf (due to the deletion of Cg-aftB), an
11% increase in 5-Araf residues can be observed in the C. glutam-
icumDaftBDaftD double mutant as compared to the wild type
(Fig. 2A and Table 1). Most interesting is the apparent re-
appearance of a peak with a retention time similar to 2-Araf
(11.5 min), but with a completely different mass fragmentation
pattern (Fig. 2B). This particular residue is unique to C. glutam-
icumDaftBDaftD, and the data support a 3-Araf unit (Fig. 2B). Trans-
formation of C. glutamicumDaftBDaftD with plasmids expressing
Fig. 2. Gas Chromatography/Mass Spectrometry (GC/MS) analysis of partially per-O-methylated, per-O-acetylated alditol acetate derivatives of purified arabinogalactan from
C. glutamicum, C. glutamicumDaftB, C. glutamicumDaftD and C. glutamicumDaftBDaftD. A, gas chromatograms demonstrating the presence of glycosyl linkages in purified AG. B,
mass spectra fragmentation profile of peaks resolving at 11.3 min corresponding to 2-Araf (*) and 3-Araf (**) and cleavage ions representing fragmentation of 2-Araf (*) and 3-
Araf (*) located in terminal arabinan glycosyl motifs.
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phenotype to one which is identical to that of C. glutamicumDaftB,
thus demonstrating that Cg-aftD and Mt-aftD both have an equal
capacity for complementation of the chromosomally deleted ver-
sion of Cg-aftD (Fig. S5 and Table 1). These results strongly support
the notion that both Cg-aftD and Mt-aftD are directly involved in
some aspect of D-arabinan cell wall biosynthesis, most likely
through an AraT enzyme with a distinctive a(1? 5) transferase
activity. To further corroborate our hypothesis that AftD is an
a(1? 5) AraT, we performed individual 1H, 13C HSQC 2D-NMR
scans of highly purified base solubilised AG isolated from
C. glutamicum WT, C. glutamicumDaftB, C. glutamicumDaftD and
C. glutamicumDaftBDaftD (Fig. S6). Interpretation of the expanded
anomeric region obtained from C. glutamicum revealed a complex
pattern of spin systems linked to the AG polysaccharide
(Fig. S6A). By relating these data to similarly published information
(Birch et al., 2008, Lee et al., 2005, Liu et al., 2011, Mahrous et al.,
2008), we fully assigned each of the resonances I-X (Fig. S6A). As
expected, resonances corresponding to positions I, II and III are
absent in the spectra obtained from AG isolated from
C. glutamicumDaftB, confirming a complete loss of terminal
b(1? 2)-Araf residues at the non-reducing end of the arabinan
domain (Fig. S6B). In terms of AG prepared from
C. glutamicumDaftD, initial inspection of the spectra (in comparison
to the WT spin systems) indicates a full complement of residues
present within the AG of this mutant, which is similar to the earlier
GC/MS results (Fig. 2A). However, a slight reduction in the volume
and intensity of peak IV (5-Araf, spin system d 111.01 ppm/d
5.03 ppm) is evident. Taken together the GC/MS data (Fig. 2), lends
further support to our hypothesis that AftD is an a(1? 5)arabinofuranosyl transferase. Analysis of AG spectra from
C. glutamicumDaftBDaftD highlights two noteworthy differences
when compared to the WT spin systems. First, there is a prominent
increase in the volume and intensity of peak IV (5-Araf, spin
system d 111.01 ppm/d 5.03 ppm) relating to a large increase in
the overall abundance of Araf in the AG isolated from
C. glutamicumDaftBDaftD (Fig. S6D). This result also correlates
directly with our data describing a large increase in Araf from
the total sugar compositional analysis of C. glutamicumDaftBDaftD
(Fig. 2 and Table 1). Second, the new spin system XI (d 110.6 ppm/d
5.11 ppm) is also clearly present, which we have assigned as
corresponding to the introduction of an a-3-Araf linkage
(Fig. S6D). Collectively, our chemical analysis of AG isolated from
both C. glutamicumDaftD and C. glutamicumDaftBDaftD mutants
implicates AftD as an a(1? 5) AraT.
In vitro arabinofuranosyltransferase activity from cell-free extracts of
C. glutamicum and mutant strains using neo-glycolipid acceptors and
p[14C]Rpp
We selected two neo-glycolipid acceptors to use as molecular
probes for analysing AraT activity, a linear disaccharide
a-D-Araf(1? 3)-a-D-Araf-O-(CH2)7CH3 (acceptor A) and a
branched trisaccharide [a-D-Araf(1? ]3,5-a-D-Araf-O-(CH2)7CH3
(acceptor B). By implementing a well established AraT assay
(Birch et al., 2008, Lee et al., 1997) we first assessed the array of
products formed from incubating acceptor A and acceptor B
(independently) with p[14C]Rpp and membranes prepared from
C. glutamicum and each mutant strain, supplemented with deca-
prenol monophosphate. Assays were conducted both in the
Fig. 3. Arabinofuranosyltransferase activity utilizing neoglycolipid acceptor A and membranes prepared from C. glutamicum, C. glutamicumDaftB, C. glutamicumDaftD and C.
glutamicumDaftBDaftD. A, Arabinofuranosyltransferase activity was determined using the synthetic neoglycolipid acceptor a-D-Araf(1? 3)-a-D-Araf-O-(CH2)7CH3 (acceptor
A) in a cell-free assay with and without EMB (100 lg/ml) as previously described (Lee et al., 1997). The products of the assay were resuspended prior to scintillation counting
(10%) and the remaining subjected to TLC using silica gel plates (5735 silica gel 60F254, Merck) in isopropanol:acetic acid:water (8:1:1, v/v/v) with the reaction products
visualized by autoradiography. The TLC autoradiogram is representative of several independent experiments. B, biosynthetic reaction scheme of products A1, A2 and A3
formed in arabinofuranosyltransferase assays using the neoglycolipid acceptor A. C, GC/MS analysis of the partially per-O-methylated, per-O-acetylated alditol acetate
derivative of reaction products obtained from assays containing membranes prepared from either C. glutamicum, C. glutamicumDaftB, C. glutamicumDaftD and C.
glutamicumDaftBDaftD.
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Fig. 4. Arabinofuranosyltransferase activity utilizing neoglycolipid acceptor B and membranes prepared from C. glutamicum, C. glutamicumDaftB, C. glutamicumDaftD and C.
glutamicumDaftBDaftD. A, Arabinofuranosyltransferase activity was determined using the synthetic neoglycolipid acceptor [a-D-Araf(1? ]3,5-a-D-Araf-O-(CH2)7CH3
(acceptor B) in a cell-free assay with and without EMB (100 lg/ml) as previously described (Lee et al., 1997). The products of the assay were resuspended prior to scintillation
counting (10%) and the remaining subjected to TLC using silica gel plates (5735 silica gel 60F254, Merck) in isopropanol:acetic acid:water (8:1:1, v/v/v) with the reaction
products visualized by autoradiography. The TLC autoradiogram is representative of several independent experiments. B, Biosynthetic reaction scheme of products B1, B2 and
B3 formed in arabinofuranosyltransferase assays using the neoglycolipid acceptor B. C, GC/MS analysis of the partially per-O-methylated, per-O-acetylated alditol acetate
derivative of reaction products obtained from assays containing membranes prepared from either C. glutamicum, C. glutamicumDaftB, C. glutamicumDaftD and C.
glutamicumDaftBDaftD.
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10 L.J. Alderwick et al. / The Cell Surface 1 (2018) 2–14absence and presence of EMB in order to inhibit the single Emb
protein which, under standard assay conditions, accounts for the
majority of 5-Araf residues deposited into endogenous AG precur-
sors as well as neo-glycolipid acceptors (Birch et al., 2008). Follow-
ing organic solvent extraction and separation of [14C]-labelled
reaction products by TLC (from acceptor A), autoradiography
revealed the presence of two bands that migrate to a Rf of 0.3 or
0.41, which we labelled product A1 and product A2&3, respectively
(Fig. 3A). For acceptor B, a similar profile was observed with two
bands either migrating to a Rf of 0.24 or 0.35, which we labelled
product B1 and product B2&3, respectively (Fig. 4A). Assays con-
ducted using wild type membranes and either acceptor A or B, pro-
duce a TLC autoradiogram with a product profile comprised of a
single band annotated as product A1 and product B1, respectively,
and is unaltered when EMB is included in the reaction mix
(Figs. 3A and 4A). This combination of bands visible on the TLC
changes significantly when assays are repeated using membranes
devoid of AftB activity, suggesting that the slower migrating prod-
ucts (product A1 and product B1) produced from wild type C. glu-
tamicum membranes contain [14C]Araf-b(1? 2) residues (Seidel
et al., 2007a) by the AraT activity of AftB which dominates under
standard assay conditions (Figs. 3AB and 4AB). The faster migrating
bands, which appear in assays conducted with membranes pre-
pared from either C. glutamicumDaftB or C. glutamicumDaftBDaftD
(irrespective of whether acceptor A or acceptor B was used), have
been labelled as product A2&3 (for acceptor A) and product B2&3
(for acceptor B). It is clear that for both of the acceptors (A and
B) used in these assays, the formation of the resultant product
migrating fastest on the TLC is sensitive to EMB suggesting that
its appearance is, in part, due to the presence of the single Emb
AraT and therefore contains an [14C]Araf-a(1? 5) residue (product
A2 and B2) attached to both of the acceptors in question
(Figs. 3AB and 4AB). However, assays conducted using membranes
prepared from C. glutamicumDaftB supplemented with EMB pro-
duces a faintly visible band migrating to the same position on
the TLC to assays conducted in the absence of EMB (hence the
annotation of this band as product A2&3), suggesting the existence
of an additional residual [14C]Araf-a(1? 5) AraT activity which is
insensitive to EMB (product A3) (Fig. 3AB). Interestingly, assays
conducted with membranes devoid only of AftD produce an iden-
tical TLC profile to that of the wild type assays, which is due to the
‘‘dominant” endogenous AraT activity of AftB, even in the presence
of EMB (Figs. 3A and 4A). We have previously observed this dom-
inant AftB activity when performing glycosyltransferase assays
using similar neoglycolipid acceptors (Birch et al., 2008, Lee
et al., 1997, Seidel et al., 2007a). In addition to the a(1? 5) AraT
activity of Emb, these radiolabelled assays provide indicative evi-
dence for the presence of another a(1? 5) AraT (vis a vis to pro-
duct A3 and B3) endogenous to C. glutamicum.
Evidence showing AftD exerts a(1? 5) arabinofuranosyltransferase
activity
In an effort to assign AftD with corresponding biochemical func-
tion, in terms of specific arabinofuranosyltransferase activity, we
repeated scaled-up AraT assays using non-radiolabelled substrates.
This experimental approach enabled production of sufficient quan-
tities of reaction products to allow for subsequent chemical charac-
terisation via GC/MS and electrospray mass spectrometry (ES-MS).
Our attempts to extract individual bands (in isolation) from
preparative TLCs were thwarted due to the technically challenging
nature of closeness in retardation factors of the reaction products.
Therefore, we analysed the ‘‘total pool of reaction products” in
order to determine what array of glycosidic linkages resulted from
the incubation of either acceptors A and B with the various strains
of C. glutamicum membrane preparations. Assays conducted usingacceptor A and C. glutamicummembranes resulted in the formation
of at least three products made possible by the endogenous
b(1? 2) and a(1? 5) AraT activities of AftB, Emb and AftD respec-
tively (Fig. 3B), which upon addition of EMB, induced a complete
loss in the formation of 3,5-Araf (Fig. 3C). ES-MS analysis of per-
O-methylated products resulted in a major peak at m/z of 647
(624 + Na) indicating that all products extracted exist as a trisac-
charide (data not shown). As expected, when membranes from
C. glutamicumDaftB were used in combination with acceptor A,
all residual b(1? 2) activity was abolished due to the removal of
the AftB enzyme (Seidel et al., 2007a) (Fig. 3C). Chemical analysis
of reaction products resulting from assays repeated in the presence
of EMB revealed a linkage profile that fits a situation in which one
can only conclude that a single a(1? 5) Araf has been incorpo-
rated into the acceptor substrate (Fig. 3B and C). Importantly, this
product corresponds to an a-D-Araf(1? 5)-a-D-Araf(1? 3)-a-D-
Araf-O-(CH2)7CH3 trisaccharide product (product A3), which is also
confirmed by a single ion at an m/z of 647 (624 + Na) (data not
shown). Interestingly, the peak corresponding to 5-Araf is missing
from the C. glutamicumDaftD assay products (product A3) with an
additional loss of 3,5-Araf when assays are repeated in the pres-
ence of EMB (Fig. 3C). Under these experimental conditions, the
absence of AftD activity due to the deletion of aftD in combination
with the chemically induced inactivation of Emb by EMB, only
results in the formation of product A1 catalysed by AftB
(Fig. 3B and C). The AraT activity of Emb can be clearly observed
in the results obtained from experiments carried out using mem-
branes isolated from C. glutamicumDaftBDaftD, which corresponds
to the formation of product A2. A repetition of these assays supple-
mented with EMB revealed a ‘‘blank” chromatogram with a linkage
profile comprised only of background ‘‘noise” and can be attributed
to a nullification of all AraT activity, either as a result of genetic
deletion or chemical inhibition by EMB (Fig. 3C). This expected
result is also in accordance with the radiolabelled experiments pre-
viously described (Fig. 3A).
Each of the assays described above were, in essence, repeated
like-for-like using acceptor B. This 3,5-Araf branched tri-
arabinoside neo-glycolipid acceptor was used to determine what
the effect an additional a(1? 5) Araf residue had on the resultant
product profiles obtained from cell free assays conducted using
membranes produced from each of the C. glutamicum strains under
investigation. Assays conducted using acceptor B and C. glutam-
icum membranes resulted in the formation of at least three major
products (Fig. 4B) arising from endogenous b(1? 2) and a(1? 5)
AraT activities of AftB, Emb and AftD respectively, which upon
addition of EMB, caused a reduction in the peak corresponding to
5-Araf (Fig. 4C). ES-MS analysis of per-O-methylated products
resulted in two dominant ions appearing at m/z 807 (784 + Na)
and 967 (944 + Na) indicating that the products extracted consist
of a pool of tetrasaccharides and pentasaccharides (data not
shown). As expected, when membranes from C. glutamicumDaftB
were used in combination with acceptor B, all endogenous
b(1? 2) activity was abolished due to the removal of the AftB
enzyme (Seidel et al., 2007a) (Fig. 4C). Chemical analysis of reac-
tion products resulting from assays repeated in the presence of
EMB revealed a linkage profile that fits a situation in which one
can only conclude that a single a(1? 5) Araf has been incorpo-
rated into the acceptor substrate (Fig. 4B and C). Whilst we cannot
unequivocally claim that this a(1? 5) Araf residue has been added
to the 3-arm branch of acceptor B, the evidence gathered so far
suggest that this is the likely position of insertion which corre-
sponds to a tetrasaccharide product (product B3), which is also
confirmed by a single ion at an m/z 807 (784 + Na) (data not
shown). Interestingly, the peak corresponding to 5-Araf is reduced
in the C. glutamicumDaftD assay products and when assays are
repeated in the presence of EMB this peak is completely abolished
L.J. Alderwick et al. / The Cell Surface 1 (2018) 2–14 11(Fig. 4C). Under these experimental conditions, the absence of AftD
activity due to deletion of aftD in combination with the chemically
induced inactivation of Emb by the front line drug EMB, only
results in the formation of product B1 catalysed by AftB
(Fig. 4A and B). The AraT activity of Emb can be clearly observed
in the results obtained from experiments carried out using mem-
branes isolated from C. glutamicumDaftBDaftD. This product profile
closely resembles that of assays carried out using C. glutam-
icumDaftB supplemented with EMB and therefore lends supporting
evidence that Emb is responsible for the formation of product B2
(Fig. 4A and B). A repetition of these assays supplemented with
EMB again reveals a ‘‘blank” chromatograph with a linkage profile
comprised only of background ‘‘noise” (Fig. 4C).
As part of this investigation we wanted to investigate the bio-
chemical function of the M. tuberculosis ortholog of AftD. Our
attempts to study Mt-AftD as recombinant protein have been ham-
pered due to the extensive hydrophobic nature of this protein.
Therefore, in order to study the biochemistry of Mt-AftD, we made
further use of the previously described cell free assay which con-
tains membranes prepared from C. glutamicumDaftBDaftD contain-
ing Mt-AftD via the aid of an over expression plasmid. In this
instance, all isolated membranes are devoid of residual AftB and
Cg-AftD activity and the a(1? 5) Araf transferase activity of Emb
was abolished by supplementing all assay reactions with EMB. This
created an experimental situation which enabled us to make a
direct study of Mt-AftD expressed into a native Corynebacteriales
membranous system. When assays were carried out using acceptor
A, chemical analysis of the products by GC/MS revealed a linkage
profile (Fig. 5A) almost identical to that of the products being
formed from the previously observed C. glutamicumDaftB + EMB
(Fig. 3BC). ES-MS analysis of this product revealed a major ion at
647 m/z (Fig. 5C), suggesting that this trisaccharide product is in
fact a-D-Araf(1? 5)-a-D-Araf(1? 3)-a-D-Araf-O-(CH2)7CH3 (pro-
duct A3, Fig. 3B). When assays were carried out using acceptor B,
chemical analysis of the products by GC/MS revealed a linkage pro-
file (Fig. 5B) almost identical to that of the products being formed
from the previously observed C. glutamicumDaftB + EMB (Fig. 4BC).
ES-MS analysis of this product revealed a major ion at 807 m/z
(Fig. 5D), suggesting that this tetrasaccharide product is in fact
a-D-Araf(1? 5) extension of the 3-arm of acceptor B yielding a
product B3 (Fig. 4B).
Discussion
During our earlier studies, we discovered the role of AftA
(Alderwick et al., 2006b), AftB (Seidel et al., 2007a) and AftC
(Birch et al., 2008) which has shed new light on how members
belonging to the Corynebacteriales (such as C. glutamicum and M.
tuberculosis) synthesise their cell walls. We conducted a bioinfor-
matic analysis of a variety of Corynebacteriales genomes looking
specifically for ORFs encoding for GT-C glycosyltransferases. Many
of these ORFs have now been assigned a function, either belonging
to AG biosynthesis and/or LM/LAM (Abrahams and Besra, 2016,
Jankute et al., 2015). Apart from Rv0051, which remains to be
assigned its proper function, Rv0236c (AftD) presented itself as a
potential candidate to be involved in the assembly of the M. tuber-
culosis cell wall. We speculated that AftD might encode for a GT-C
glycosyltransferase that provided a(1? 5) arabinofuranosyltrans-
ferase activity, possibly elongating the 3-arm of the arabinan
domain in a processive manner. Contrary to the findings reported
by Skovierova et al. (2009) our chemical analysis of the C. glutam-
icumDaftD cell wall revealed a clear phenotype. The main differ-
ence being a 1.5-fold increase in the amount of TMCM
deposited into the cell wall with a corresponding 7% decrease in
arabinogalactan-related cell wall arabinose. The severity of this
change in cell wall phenotype is exacerbated when both aftB andaftD are deleted in C. glutamicum and further glycosidic linkage
analysis by GC/MS and HSQC 2D-NMR provides evidence that AftD
is involved in formation of AG in C. glutamicum. Specifically, whilst
deletion of aftD causes a slight reduction in the amount of 5-Araf
relative, a double deletion of aftB and aftD induces additional and
unique alterations to the glycosidic linkage profiles manifested
by the appearance of a 3-Araf residue. This motif can only appear
in a situation whereby a terminal Araf residue is positioned on
the 3-OH of a preceding Araf residue on the arabinan polymer.
Skovierova et al. (2009) demonstrated that AftD fromM. smegmatis
displays a(1? 3)-Araf transferase activity. Whilst we fully
acknowledge the findings of these authors, this study now provides
new evidence demonstrating that both Cg-AftD and Mt-AftD exhi-
bit a(1? 5)-Araf transferase activity.
By taking a review of all publications (post-2005) concerning
the biosynthesis of the mycobacterial cell wall, including the find-
ings of this report, only now are we able to fully appreciate the
intricate mechanisms by which this pathogen assembles its cell
wall (Fig. 6). The galactan domain of AG is first synthesised within
the cytoplasm of the cell, which is in turn conjugated to decaprenol
pyrophosphate via a unique GlcNAc-Rha linker unit. Once this lin-
ear polysaccharide has been translocated across the cytoplasmic
membrane (Dianiskova et al., 2011), AftA inserts three Araf resi-
dues at the 8th, 10th and 12th position of the galactan domain
(Alderwick et al., 2006b). In the case of C. glutamicum, the single
Emb protein then serves to processively extend each of the
‘‘primed” Araf residues with a(1? 5)-Araf residues to an optimal
length (approximately 5–6 residues) before AftC adds an
a(1? 3)-Araf unit. This sequence of events is most likely to be
the case in Mycobacterium spp. but with either EmbA or EmbB pro-
viding a(1? 5) AraT activity. The generation of a newly synthe-
sised branched arabinan ‘‘motif” is a critical event leading to the
bifurcation of the arabinan domain. Whilst the molecular mecha-
nism of this requires further investigation, it is tempting to suggest
that a branching of the arabinan oligosaccharide induces differen-
tial affinities between the acceptor substrate (Km) and the next
AraT. In this regard, data from this study suggest that AftD recog-
nises the 5-OH of a 3-Araf and Emb (or EmbA or EmbB in the case
ofMycobacterial spp.) recognises the 5-OH of the 5-Araf of the main
arabinan chain (Fig. 6). This mechanism has been demonstrated in
the globular C-terminal domain of EmbC, which shows differential
affinities for a variety of arabinan oligosaccharides that differ in
length (Alderwick et al., 2011). By an as yet unknown mechanism,
the AraTs are then able to distinguish between a variety of arabi-
nan chain lengths by introducing a 3,5-Araf residue before AftB
completes arabinan biosynthesis by ‘‘capping” the 3,5-Araf motif
with two terminal b(1? 2) residues (Fig. 6). The structural com-
plexity of mycobacterial D-arabinan is mirrored in the equally
complex biosynthetic systems that have evolved to assemble this
crucial cell wall molecule. We have shown that many of these gly-
cosyltransferases interact with each other in a combination of
homo and hetero oligomeric complexes (Jankute et al., 2014). For
instance, both AftA and AftB directly interact with Emb and AftC,
likely forming a large membrane bound multi-enzyme complex
(Jankute et al., 2014). Interestingly, our analysis of AG prepared
from the C. glutamicumDaftBDaftD mutant in this study reveals a
significant increase in 5-Araf glycosyl linkages. In this situation,
due to complete absence of b(1? 2)-Araf and a(1? 5)-Araf activ-
ity (from AftB and AftD, respectively), extension of the D-arabinan
is reliant upon the remaining endogenous a(1? 3)-Araf and
a(1? 5)-Araf transferase activities from AftC and Emb, respec-
tively. We speculate that this phenotype could be partly rationa-
lised by disruption multi-enzyme complex that work in concert
to synthesise mycobacterial D-arabinan. Further studies are
needed to investigate the precise molecular mechanisms by which
all the variants of the AraT family of enzymes work in concert to
Fig. 5. GC/MS and ES-MS characterisation of in vitro synthesized reaction products from the arabinofuranosyltransferase assays utilizing both acceptors A and B. A, GC/MS
analysis and B, ES-MS analysis of products derived from assays using acceptor A and membranes prepared from C. glutamicumDaftBDaftD over-expressing Mt-aftD
supplemented with EMB. C, GC/MS analysis and D, ES-MS analysis of products derived from assays using acceptor B and membranes prepared from C. glutamicumDaftBDaftD
over-expressing Mt-aftD supplemented with EMB.
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Fig. 6. Revised pathway of arabinan biosynthesis illustrating the individual roles of Emb, AftA, AftB, AftC and AftD arabinofuranosyltransferases.
L.J. Alderwick et al. / The Cell Surface 1 (2018) 2–14 13produce AG, which is crucial to the structural integrity of the
mycobacterial cell wall.
Significance
One of the greatest burdens on humanity is the continued rise
and prevalence of TB. New chemotherapeutic agents are urgently
required to combat this human pathogen especially with the
advent of multi-drug-resistant (MDR) and extensively-drug-
resistant (XDR) strains of M. tuberculosis. Arabinogalactan (AG) is
an essential cell wall molecule and its formation is targeted by
treating TB patients with the front line drug, ethambutol. This
study focuses on AftD, an essential enzyme in this pathway.
Through a comprehensive phenotypic characterisation of both sin-
gle and double mutants of C. glutamicum devoid of aftD and aftB,
combined with detailed biochemical AraT assays, we have decon-
voluted the molecular genetics of aftD in terms of its involvement
in D-arabinan biosynthesis as an a(1? 5)-Araf transferase.
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